A Phase IIb Randomized Controlled Trial Investigating the Effects of Tocotrienol-Rich Vitamin E on Diabetic Kidney Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Phase IIb Randomized Controlled Trial Investigating the Effects of Tocotrienol-Rich Vitamin E on Diabetic Kidney Disease
Authors
Keywords
-
Journal
Nutrients
Volume 13, Issue 1, Pages 258
Publisher
MDPI AG
Online
2021-01-20
DOI
10.3390/nu13010258
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Dose Vitamin E Attenuates Diabetic Nephropathy via Alleviation of Autophagic Stress
- (2019) Yuxue Zhao et al. Frontiers in Physiology
- Antioxidant, Anti-Inflammatory, and Metabolic Properties of Tocopherols and Tocotrienols: Clinical Implications for Vitamin E Supplementation in Diabetic Kidney Disease
- (2019) Angelo Di Vincenzo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The global burden of kidney disease and the sustainable development goals
- (2018) Valerie A Luyckx et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Targeting TGF-β Signaling in Kidney Fibrosis
- (2018) Yoshitaka Isaka INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial
- (2018) Suzanne Tan et al. Nutrients
- What can target kidney fibrosis?
- (2017) Irina A Leaf et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients
- (2017) Jeong Uk Lim et al. International Journal of Chronic Obstructive Pulmonary Disease
- Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease
- (2016) Michelle J. Pena et al. DIABETOLOGIA
- Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol
- (2016) Hong Yong Peh et al. PHARMACOLOGY & THERAPEUTICS
- Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials
- (2016) Xin Mou et al. PLoS One
- Validation of a HPLC/FLD Method for Quantification of Tocotrienols in Human Plasma
- (2015) Hui-Ling Che et al. International Journal of Analytical Chemistry
- Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
- (2015) Stephanie Toth-Manikowski et al. Journal of Diabetes Research
- Influence of Vitamin E Supplementation on Glycaemic Control: A Meta-Analysis of Randomised Controlled Trials
- (2014) Renfan Xu et al. PLoS One
- Protective effects of tocotrienols against lipid-induced nephropathy in experimental type-2 diabetic rats by modulation in TGF-β expression
- (2013) Shabeena Siddiqui et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The 21st Century Form of Vitamin E - Tocotrienol
- (2011) Jayeeta Bardhan et al. CURRENT PHARMACEUTICAL DESIGN
- A study of the natural history of diabetic kidney disease (DKD)
- (2011) N. Altemtam et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Tocotrienols, the vitamin E of the 21st century: Its potential against cancer and other chronic diseases
- (2010) Bharat B. Aggarwal et al. BIOCHEMICAL PHARMACOLOGY
- Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2010) P. L. Drury et al. DIABETOLOGIA
- Effects of vitamin E supplementation on glycaemic control in type 2 diabetes: systematic review of randomized controlled trials
- (2010) N. Suksomboon et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started